Learn to reduce HPLC method development cost in 12 easy steps.
Reducing HPLC Method Development Cost is a challenging task for a chromatographer, but it can be achieved with a scientific approach.
HPLC is one of the most essential and widely used analytical techniques in pharmaceutical development. However, developing and validating a robust HPLC method can often be time-consuming, resource-intensive, and costly.The good news is that with a strategic and systematic approach, it is possible to streamline method development while keeping expenses under control—without compromising quality, regulatory compliance, or data integrity.
In this skill-based blog, we will explore practical steps and proven procedures to effectively reduce HPLC method development costs while maintaining high analytical standards.
Boost your pharma career with PharmaGuru’s expert-led online courses.: Online Pharma Course (Training)
The following are 11 key steps to reduce the HPLC analysis cost:
One of the most overlooked cost-saving steps is proper planning. Before beginning experimental work, define:
Adopt QBD (quality by design approach) to avoid unnecessary experiments and method over-design.
Whenever feasible, aim to develop a single, common HPLC method that can be applied across multiple analytical requirements—such as assay, related substances testing, and in-process control (IPC) analysis.
Designing a unified method for reaction monitoring, purity determination, assay, and related substances evaluation can significantly reduce overall analysis time, solvent consumption, column usage, and method maintenance efforts. Instead of managing and validating multiple separate methods, a well-optimized common method streamlines laboratory workflow, simplifies documentation, and lowers operational costs.
If scientifically justifiable and compliant with regulatory expectations, a multi-purpose HPLC method is one of the most effective strategies to dramatically reduce analytical costs while improving efficiency and consistency.
Rather than starting from scratch, review literature, pharmacopoeias (USP, EP), or internal databases for similar compounds or formulations. Adapting or modifying existing methods is far more cost-effective than developing new ones.
Modern method development software like DryLab, Fusion QbD, or AutoChrom can simulate thousands of chromatographic conditions with just a few experiments. Benefits include:
This drastically reduces solvent, column wear, and analyst time.
Start with linear gradients on short columns using generic conditions (e.g., C18 column, 5–95% acetonitrile gradient). This provides a rapid overview of compound behaviour, helping narrow down optimum conditions quickly.
Use UHPLC or short columns with smaller particle sizes during development to reduce run times and solvent use. For early-phase scouting, consider low-volume injection and shorter run times — it adds up to significant savings.
Avoid trial-and-error with dozens of columns. Instead, base column choice on:
Keep a small, well-curated library of columns covering different retention mechanisms.
Plan your lab work in blocks to minimise idle time and instrument use. If your HPLC system allows, run multiple samples or methods in parallel. Automation and sample queues help reduce analyst labour costs and improve throughput.
Using commonly stocked mobile phases (e.g., water + acetonitrile or methanol with formic acid or phosphate buffers) simplifies procurement, reduces waste, and speeds up method qualification.
Avoid exotic or unstable reagents unless necessary.
An experienced analyst can spot method flaws early, troubleshoot more effectively, and optimize faster. Likewise, well-documented methods and decision trails avoid redundant work if someone new picks up the project.
Training is an investment that pays back in both speed and quality.
Don’t over-validate. Follow ICH guidelines and focus on fitness-for-purpose. For example, impurity methods may need very low LOD/LOQ, but assay methods may not. Tailor validation depth to your actual regulatory or quality requirements.
Try to develop common chromatographic conditions/methods for multiple stages. It will reduce both analysis time and analysis cost.
If the route of synthesis (ROS) contains 7 steps, and you have to develop the HPLC method for each stage. To reduce the cost, you should try to develop the same chromatographic conditions (or similar chromatographic conditions using the same buffer, solvent and column) for all steps.
Reducing HPLC method development costs without compromising quality requires both skill and experience. By combining smart planning, the right equipment, and modern development strategies, labs can significantly cut their expenses, often by 30-50%, while still delivering robust, regulatory-compliant practices.
Related:
Begin by reviewing literature, pharmacopeial methods (e.g., USP, EP), and internal method libraries for similar compounds. Adapting existing methods is often faster and cheaper than starting from scratch
Software tools like DryLab, Fusion QbD, or ChromSword simulate chromatographic conditions based on minimal data. They help optimise parameters like gradient, pH, and column selection virtually, reducing lab time, solvent use, and column wear.
Yes. UHPLC systems reduce solvent consumption, shorten run times, and increase throughput. While initial costs are higher, long-term savings on solvents, labour, and instrument time can outweigh the investment.
Skilled analysts can identify problems early, optimize conditions faster, and avoid unnecessary experiments. Investing in training and method development best practices often yields long-term savings.
No. Skipping validation can lead to compliance issues and costly rework. However, you can tailor validation to your method’s intended use. Don’t over-validate—follow ICH guidelines and focus on what’s needed for regulatory or internal requirements.
Further Reading
Quick Links